BIOMAT Database Logo BIOMAT Database Logo

The molecular pathology of amyloid deposition in Alzheimer's disease. 1991

R N Martins, and P J Robinson, and J O Chleboun, and K Beyreuther, and C L Masters
University Department of Surgery, Repatriation General Hospital, Hollywood, Perth, Western Australia.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D011499 Protein Processing, Post-Translational Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility. Amino Acid Modification, Post-Translational,Post-Translational Modification,Post-Translational Protein Modification,Posttranslational Modification,Protein Modification, Post-Translational,Amino Acid Modification, Posttranslational,Post-Translational Amino Acid Modification,Post-Translational Modifications,Post-Translational Protein Processing,Posttranslational Amino Acid Modification,Posttranslational Modifications,Posttranslational Protein Processing,Protein Processing, Post Translational,Protein Processing, Posttranslational,Amino Acid Modification, Post Translational,Modification, Post-Translational,Modification, Post-Translational Protein,Modification, Posttranslational,Modifications, Post-Translational,Modifications, Post-Translational Protein,Modifications, Posttranslational,Post Translational Amino Acid Modification,Post Translational Modification,Post Translational Modifications,Post Translational Protein Modification,Post Translational Protein Processing,Post-Translational Protein Modifications,Processing, Post-Translational Protein,Processing, Posttranslational Protein,Protein Modification, Post Translational,Protein Modifications, Post-Translational
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia

Related Publications

R N Martins, and P J Robinson, and J O Chleboun, and K Beyreuther, and C L Masters
Amyloid deposition in Alzheimer's disease.
January 1993, Annals of clinical and laboratory science,
R N Martins, and P J Robinson, and J O Chleboun, and K Beyreuther, and C L Masters
Molecular pathology of the amyloid A4 precursor of Alzheimer's disease.
January 1989, Progress in clinical and biological research,
R N Martins, and P J Robinson, and J O Chleboun, and K Beyreuther, and C L Masters
Mechanisms of amyloid deposition in Alzheimer's disease.
January 1991, Annals of the New York Academy of Sciences,
R N Martins, and P J Robinson, and J O Chleboun, and K Beyreuther, and C L Masters
Anti-diabetic vanadyl complexes reduced Alzheimer's disease pathology independent of amyloid plaque deposition.
January 2019, Science China. Life sciences,
R N Martins, and P J Robinson, and J O Chleboun, and K Beyreuther, and C L Masters
Molecular pathology of Alzheimer's disease in sporadic and familial Alzheimer's disease with mutations in the amyloid precursor protein.
August 1992, Biochemical Society transactions,
R N Martins, and P J Robinson, and J O Chleboun, and K Beyreuther, and C L Masters
Early Detection of Amyloid β Pathology in Alzheimer's Disease by Molecular MRI.
July 2020, Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference,
R N Martins, and P J Robinson, and J O Chleboun, and K Beyreuther, and C L Masters
Amyloid β and Alzheimer's Disease: Molecular Updates from Physiology to Pathology.
April 2023, International journal of molecular sciences,
R N Martins, and P J Robinson, and J O Chleboun, and K Beyreuther, and C L Masters
Immunotherapy against amyloid pathology in Alzheimer's disease.
October 2013, Journal of the neurological sciences,
R N Martins, and P J Robinson, and J O Chleboun, and K Beyreuther, and C L Masters
Gangliosides determine the amyloid pathology of Alzheimer's disease.
August 2009, Neuroreport,
R N Martins, and P J Robinson, and J O Chleboun, and K Beyreuther, and C L Masters
The genetics and molecular pathology of Alzheimer's disease: roles of amyloid and the presenilins.
November 2000, Neurologic clinics,
Copied contents to your clipboard!